Treating epilepsy across its different stages

Therapeutic Advances in Neurological Disorders

Volumn 3, Issue 2, 2010, Pages 85-92

  Beghi, Ettore ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

acute symptomatic seizures; antiepileptic drugs; epilepsy; treatment discontinuation

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADD ON THERAPY; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM; CHILD; CLINICAL TRIAL; CRANIOTOMY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; EMOTIONALITY; EPILEPSY; FEBRILE CONVULSION; FOCAL EPILEPSY; GRAND MAL SEIZURE; GROUPS BY AGE; HUMAN; LONG TERM CARE; MAINTENANCE DRUG DOSE; MONOTHERAPY; NEUROIMAGING; PREGNANCY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RELAPSE; REVIEW; SEIZURE; SIDE EFFECT; SOCIAL ASPECT; SYMPTOMATIC EPILEPSY; TRAUMATIC BRAIN INJURY;

EID: 77953416798     PISSN: 17562856     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756285609351945     Document Type: Review

References (39)

1. Annegers, J.F., Hauser, W.A. and Elveback, L.R. ( 1979) Remission of seizures and relapse in patients with epilepsy. Epilepsia 20: 729-737.
2. Beghi, E. ( 2004) Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol 3: 618-621.
3. Beghi, E. ( 2007) Treatment of first unprovoked seizure. In: Ryvlin, P., Beghi, E., Camfield, P. and Hesdorffer, D. (eds), From First Unprovokes Seizure to Newly Diagnosed Epilepsy, John Libbey Eurotext : Montrouge, pp. 157-168.
4. Beghi, E., de Maria, G., Gobbi, G. and Veneselli, E. ( 2006) Diagnosis and treatment of the first epileptic seizure: Guidelines of the Italian League Against Epilepsy. Epilepsia 47(Suppl. 5): 2-8.
5. Beghi, E., Gatti, G., Tonini, C., Ben-Menachem, E., Chadwick, D.W., Nikanorova, M. et al. (2003) Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controller trial. Epilepsy Res 57: 1-13.
6. Beghi, E., Leone, M., Torelli, P., Bogliun, G., Boccagni, C., Rocchi, R. et al. (2005) Multicenter therapeutic trial comparing standard with low doses of antiepileptic drugs in patients with newly diagnosed patients. Neurological Sci 26(Suppl): S40.
7. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D.C., Malmgren, K., Sander, J.W. et al. (2009) Recommendation for a definition of acute symptomatic seizure. Epilepsia Sep 3 [Epub ahead of print].
8. Berg, A.T. ( 2008) Risk of recurrence after a first unprovoked seizure. Epilepsia 49(suppl 1): 13-18.
9. Berg, A.T. and Shinnar, S. ( 1991) The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 41: 965-972.
10. Berg, A.T. and Shinnar, S. ( 1994) Relapse following discontinuation of antiepileptic drugs: A meta-analysis. Neurology 44: 601-608.
11. Bialer, M. ( 2005) The pharmacokinetics and interactions of new antiepileptic drugs: an overview. Ther Drug Monitor 27: 722-726.
12. Chadwick, D., Taylor, J. and Johnson, T. ( 1996) Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. Epilepsia 37: 1043-1050.
13. Chadwick, D. ( 1999) Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomized DB study: Vigabatrin European Monotherapy Study Group. Lancet 354: 13-19.
14. Commission on Epidemiology and Prognosis, International League Against Epilepsy. (1993) Guidelines for epidemiologic studies on epilepsy. Epilepsia 34: 592-596.
15. Deckers, C.L.P., Hekster, Y.A., Keyser, A., van Lier, H.J., Meinardi, H. and Renier, W.O. ( 2001) Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study. Epilepsia 42: 1387-1394.
16. First Seizure Trial Group. (1993) Randomized clinical trial of the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology 43: 478-483.
17. Fisher, R.S., van Emde Boas, W., Blume, W., Elger, C., Genton, P., Lee, P. et al. (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy. Epilepsia 46: 470-472.
18. Glauser, T., Ben-Menachem, E., Bourgeois, B., Cnaan, A., Chadwick, D., Guerreiro, C. et al. (2006) ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 47: 1094-1120.
19. Guerreiro, M.M., Vigonius, U., Pohlmann, H., de Manreza, M.L., Fejerman, N., Antoniuk, S.A. et al. (1997) A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 27: 205-213.
20. Hauser, W.A., Rich, S.S., Lee, J.R.-J., Annegers, J.F. and Anderson, V.E. ( 1998) Risk of recurrent seizures after two unprovoked seizures. New Eng J Med 338: 429-434.
21. Hesdorffer, D.C., Benn, E.K., Cascino, G.D. and Hauser, W.A. (2009) Is acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia 50: 1102-1108.
22. Kim, L.G., Johnson, T.L., Marson, A.G. and Chadwick, D.W. ( 2006) Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. Lancet Neurol 5: 317-322.
23. Loscher, W., Honack, D. and Rundfeldt, C. ( 1998) Antiepileptic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther 284: 474-489.
24. Lossius, M.I., Hessen, E., Mowinckel, P., Stavem, K., Erikssen, J., Gulbrandsen, P. et al. (2008) Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study). Epilepsia 49: 455-463.
25. Marson, A., Jacoby, A., Johnson, A., Gamble, C. and Chadwick, D. ( 2005) Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 365: 2007-2013.
26. Marson, A.G., Al-Kharusi, A.M., Alwaidh, M., Appleton, R., Baker, G.A., Chadwick, D.W. et al. (2007 a) The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblended randomized controlled trial. Lancet 369: 1000-1015.
27. Marson, A.G., Al-Kharusi, A.M., Alwaidh, M., Appleton, R., Baker, G.A., Chadwick, D.W. et al. (2007 b) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: an unblended randomized controlled trial. Lancet 369: 1016-1026.
28. Mattson, R.H., Cramer, J.A., Collins, J.F., Smith, D.B., Delgado-Escueta, A.V., Browne, T.R. et al. (1985) Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 313: 145-151.
29. MRC Antiepileptic Drug Withdrawal Group. ( 1991) Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet 337: 1175-1180.
30. Musicco, M., Beghi, E., Solari, A. and Viani, F. ( 1997) Treatment of first tonic-clonic seizure does not improbe the prognosis of epilepsy. First Seizure Trial Group (FIRST Group). Neurology 49: 991-998.
31. Perucca, E. ( 2005) Birth defects after prenatal exposure to antiepileptic drugs. Lancet Neurol 4: 781-786.
32. Pitkanen, A. ( 2002) Drug-mediated neuroprotection and antiepileptogenesis: animal data. Neurology 59(Suppl. 5): S27-S33
33. Rowan, A.J., Ramsay, R.E., Collins, J.F., Pryor, F., Boardman, K.D., Uthman, B.M. et al. (2005) New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 64: 1868-1873.
34. Schachter, S.C. ( 2002) Current evidence indicates that antiepileptic drugs are anti-ictal, not antiepileptogenic. Epilepsy Res 50: 67-70.
35. Sirven, J., Sperling, M.R. and Wingerchuck, D.M. ( 2001) Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database of Systematic Reviews 3: CD001902.
36. Specchio, L.M. and Beghi, E. ( 2004) Should antiepileptic drugs be withdrawn in seizure-free patients? CNS Drugs 18: 201-212.
37. Temkin, N.R. ( 2001) Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 42: 515-524.
38. Walia, K.S., Khan, E.A., Ko, D.H., Raza, S.S. and Khan, Y.N. ( 2004) Side-effects of antiepileptics - a review. Pain Pract 4: 194-203.
39. Zaccara, G., Franciotta, D. and Perucca, E. ( 2007) Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 48: 1223-1244.